Reactivation of Oxidized Soluble Guanylate Cyclase as a Novel Treatment Strategy to Slow Progression of Calcific Aortic Valve Stenosis: Preclinical and Randomized Clinical Trials to Assess Safety and Efficacy
Authors
Sorin V. Pislaru (ORCID: https://orcid.org/0000-0002-5256-3150)
Maurice L. Enriquez-Sarano (ORCID: https://orcid.org/0000-0003-0910-5450)
Reactivation of Oxidized Soluble Guanylate Cyclase as a Novel Treatment Strategy to Slow Progression of Calcific Aortic Valve Stenosis: Preclinical and Randomized Clinical Trials to Assess Safety and Efficacy
Sorin V. Pislaru, Maurice L. Enriquez-Sarano, Grace Casaclang‐Verzosa, Kevin Y. Cunningham et al.
Citations
16 citations
Journal
Circulation
Topics
Cardiac Valve Diseases and Treatments
Field-Weighted Citation Impact (FWCI)
22.21
article
Reactivation of Oxidized Soluble Guanylate Cyclase as a Novel Treatment Strategy to Slow Progression of Calcific Aortic Valve Stenosis: Preclinical and Randomized Clinical Trials to Assess Safety and Efficacy
Sorin V. Pislaru, Maurice L. Enriquez-Sarano, Grace Casaclang‐Verzosa, Kevin Y. Cunningham, Philip A. Araoz, Jaeyun Sung, Sushant M. Ranadive, Gurpreet Singh, Jon E. Hawkinson, Walter K. Kremers, Jordan D. Miller, Anna Bartoo, Heyu Zhang, Vuyisile T. Nkomo, Runqing Huang, Héctor I. Michelena, Hartzell Vernon Schaff, Michael J. Joyner, Carolyn M Roos, Michael A. Walters, Michael A Hagler, Bin Zhang, Zi Ye, Brandon Dunagan
article en
16 citations
Abstract
No abstract available for this paper.
Publication Tag
CirculationVol. 151(13)
Institutions
University of Minnesota (US), Mayo Clinic (US), Mayo Clinic in Arizona (US), Mayo Clinic in Florida (US)